One2Treat
Louvain-la-neuve · Founded 2023
About One2Treat
One2Treat offers clinical trial solutions emphasizing patient-focused outcomes and net treatment benefit evaluation.
Company Facts
- Founded: 2023
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: one2treat.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/one2treat-8334610 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.